Once-weekly insulin efsitora alfa versus once-daily insulin degludec in adults with type 1 diabetes (QWINT-5): a phase 3 randomised non-inferiority trial

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01804-X/abstract?utm_campaign=conferencealerts&utm_medium=email&dgcid=hubspot_email_conferencealerts_easd24&_hsenc=p2ANqtz-9MPlTQILJSIlt8mKfeqG_miAbfGdzV8pHyhvAqKvdf8zotvdJVqiNYQSryu8wrFnVHvjmkyH-sPJ2DDxbUZk-VMuryIw&_hsmi=325536824&utm_content=325536824&utm_source=hs_email